These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38354950)

  • 1. Occult liver disease: A multinational perspective.
    Vidal-Cevallos P; Flores-García N; Chávez-Tapia NC; Chalasani NP
    Ann Hepatol; 2024; 29(3):101480. PubMed ID: 38354950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies.
    Åberg F; Färkkilä M; Männistö V
    Alcohol Clin Exp Res; 2020 Feb; 44(2):384-403. PubMed ID: 31854001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of liver disease in Latin America.
    Díaz LA; Villota-Rivas M; Barrera F; Lazarus JV; Arrese M
    Ann Hepatol; 2024; 29(3):101175. PubMed ID: 37922988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver diseases: Perspective from the Philippines.
    Ornos ED; Murillo KJ; Ong JP
    Ann Hepatol; 2023; 28(3):101085. PubMed ID: 36889673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Public Health Policies on Alcohol-Associated Liver Disease in Latin America: An Ecological Multinational Study.
    Díaz LA; Idalsoaga F; Fuentes-López E; Márquez-Lomas A; Ramírez CA; Roblero JP; Araujo RC; Higuera-de-la-Tijera F; Toro LG; Pazmiño G; Montes P; Hernandez N; Mendizabal M; Corsi O; Ferreccio C; Lazo M; Brahmania M; Singal AK; Bataller R; Arrese M; Arab JP
    Hepatology; 2021 Nov; 74(5):2478-2490. PubMed ID: 34134172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
    Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
    Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017.
    Park SH; Plank LD; Suk KT; Park YE; Lee J; Choi JH; Heo NY; Park J; Kim TO; Moon YS; Kim HK; Jang HJ; Park HY; Kim DJ
    Clin Mol Hepatol; 2020 Apr; 26(2):209-215. PubMed ID: 31679316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global epidemiology of cirrhosis - aetiology, trends and predictions.
    Huang DQ; Terrault NA; Tacke F; Gluud LL; Arrese M; Bugianesi E; Loomba R
    Nat Rev Gastroenterol Hepatol; 2023 Jun; 20(6):388-398. PubMed ID: 36977794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.
    Toshikuni N; Tsutsumi M; Arisawa T
    World J Gastroenterol; 2014 Jul; 20(26):8393-406. PubMed ID: 25024597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral Hepatitis.
    Serfaty L
    Gastroenterology; 2016 Jun; 150(8):1718-22. PubMed ID: 26873400
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.
    Setiawan VW; Stram DO; Porcel J; Lu SC; Le Marchand L; Noureddin M
    Hepatology; 2016 Dec; 64(6):1969-1977. PubMed ID: 27301913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.
    Hagström H; Hegmar H; Moreno C
    United European Gastroenterol J; 2024 Mar; 12(2):168-176. PubMed ID: 38381115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
    Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
    Arab JP; Roblero JP; Altamirano J; Bessone F; Chaves Araujo R; Higuera-De la Tijera F; Restrepo JC; Torre A; Urzua A; Simonetto DA; Abraldes JG; Méndez-Sánchez N; Contreras F; Lucey MR; Shah VH; Cortez-Pinto H; Bataller R
    Ann Hepatol; 2019; 18(3):518-535. PubMed ID: 31053546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.
    Sinn DH; Gwak GY; Cho J; Son HJ; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Atherosclerosis; 2014 Jun; 234(2):270-5. PubMed ID: 24704629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
    Younossi ZM; Yilmaz Y; Yu ML; Wai-Sun Wong V; Fernandez MC; Isakov VA; Duseja AK; Mendez-Sanchez N; Eguchi Y; Bugianesi E; Burra P; George J; Fan JG; Papatheodoridis GV; Chan WK; Alswat K; Saeed HS; Singal AK; Romero-Gomez M; Gordon SC; Roberts SK; El Kassas M; Kugelmas M; Ong JP; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2296-2306.e6. PubMed ID: 34768009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.